RenovaCare Company Executives
| RCAR Stock | USD 0.0001 0.00 0.00% |
RenovaCare employs about 1 people. The company is managed by 5 executives with a total tenure of roughly 8 years, averaging almost 1.0 years of service per executive, having 0.2 employees per reported executive. Discussion of RenovaCare's management performance can provide insight into the enterprise performance.
| Harmel Rayat Chairman Chairman of the Board |
RenovaCare |
RenovaCare Management Team Effectiveness
The company has return on total asset (ROA) of (1.0399) % which means that it has lost $1.0399 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.689) %, meaning that it created substantial loss on money invested by shareholders. RenovaCare's management efficiency ratios could be used to measure how well RenovaCare manages its routine affairs as well as how well it operates its assets and liabilities.RenovaCare owns a total of 87.35 Million outstanding shares. RenovaCare holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 74.18 pct. of RenovaCare outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as RenovaCare in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of RenovaCare, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
RenovaCare Workforce Comparison
RenovaCare is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 305. RenovaCare adds roughly 1.0 in number of employees claiming only tiny portion of equities under Health Care industry.
RenovaCare Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. RenovaCare Price Series Summation is a cross summation of RenovaCare price series and its benchmark/peer.
RenovaCare Notable Stakeholders
A RenovaCare stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as RenovaCare often face trade-offs trying to please all of them. RenovaCare's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting RenovaCare's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Harmel Rayat | Chairman of the Board | Profile | |
| CPA CPA | Treasurer | Profile | |
| Robin Robinson | VP Board | Profile | |
| Alan Rubino | Consultant | Profile | |
| Jo MD | Chief Officer | Profile |
About RenovaCare Management Performance
The success or failure of an entity such as RenovaCare often depends on how effective the management is. RenovaCare management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of RenovaCare management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the RenovaCare management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. Renovacare operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.
RenovaCare Workforce Analysis
Traditionally, organizations such as RenovaCare use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare RenovaCare within its industry.RenovaCare Manpower Efficiency
Return on RenovaCare Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 4.5M | |
| Net Loss Per Executive | 894.3K | |
| Working Capital Per Employee | 582K | |
| Working Capital Per Executive | 116.4K |
Additional Tools for RenovaCare Pink Sheet Analysis
When running RenovaCare's price analysis, check to measure RenovaCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovaCare is operating at the current time. Most of RenovaCare's value examination focuses on studying past and present price action to predict the probability of RenovaCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovaCare's price. Additionally, you may evaluate how the addition of RenovaCare to your portfolios can decrease your overall portfolio volatility.